• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

“首份”分离株药敏率的重要性:真实世界数据的证据

Importance of Susceptibility Rate of 'the First' Isolate: Evidence of Real-World Data.

作者信息

Kim Sollip, Yoo Soo Jin, Chang Jeonghyun

机构信息

Laboratory Medicine, Inje University, Ilsan Paik Hospital, Goyang 10380, Korea.

Laboratory Medicine, Inje University, Sanggye Paik Hospital, Seoul 10757, Korea.

出版信息

Medicina (Kaunas). 2020 Sep 28;56(10):507. doi: 10.3390/medicina56100507.

DOI:10.3390/medicina56100507
PMID:32998192
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7600976/
Abstract

For proper antimicrobial therapy, cumulative antibiograms should be representative of geographic region and be accurate. Clinical and Laboratory Standards Institute (CLSI) guidelines recommend that only the first isolates (FI) of a species per patient are used when reporting cumulative antibiograms. However, >50% of hospitals in the United States report antibiograms of all isolates. We compared antibiograms from the FI with those from total isolates (TI). Antimicrobial data of all isolates identified in the Microbiology unit of Ilsan Paik Hospital in 2019 were retrospectively acquired from the hospital information system. The susceptibility rates to antimicrobials of , , , , , , and were analyzed by FI and TI, respectively. Isolate counts and susceptibility rates of each species for the reported antimicrobials were compared. The numbers of isolates by FI/TI were as follows: 1824/2692 , 480/1611 , and 662/1306 , and 407/953 for gram-negative bacteria and 649/1364 , 211/313 , and 323/394 for gram-positive bacteria. All antimicrobial agents showed higher susceptibility rates when calculated as FI than as TI in gram-negative bacteria except colistin: 3.7% for , 14.5% for , 8.3% for , and 7.9% for . In , 8/11 antimicrobial agents revealed higher susceptibility rates for FI than for TI. and showed lower susceptibility rates for 7/10 antimicrobial agents for FI than for TI. The oxacillin susceptibility rates of were 36.6%/30.2% with FI/TI and vancomycin susceptibility rates for were 54.1% and 49.5%, respectively. When comparing cumulative antibiograms by FI with TI using real-world data, there is a large gap for critical species requiring hospital infection control. Although FI calculation is difficult, antibiograms must be calculated as FI for proper preemptive antimicrobial therapy because FI provides proper antimicrobial susceptibility data.

摘要

为了进行恰当的抗菌治疗,累积抗菌谱应能代表所在地理区域且准确无误。临床和实验室标准协会(CLSI)指南建议,在报告累积抗菌谱时,每位患者每种细菌仅使用首次分离株(FI)。然而,美国超过50%的医院报告所有分离株的抗菌谱。我们比较了FI的抗菌谱与全部分离株(TI)的抗菌谱。回顾性地从医院信息系统获取了2019年一山白医院微生物科鉴定出的所有分离株的抗菌数据。分别分析了FI和TI对、、、、、、和的抗菌药物敏感性率。比较了每种细菌对报告抗菌药物的分离株数量和敏感性率。FI/TI的分离株数量如下:革兰阴性菌分别为1824/2692、480/1611、662/1306和407/953,革兰阳性菌分别为649/1364、211/313和323/394。除黏菌素外,在革兰阴性菌中,所有抗菌药物按FI计算时的敏感性率均高于按TI计算时的敏感性率:对为3.7%,对为14.5%,对为8.3%,对为7.9%。在中,11种抗菌药物中有8种FI的敏感性率高于TI。和中,10种抗菌药物中有7种FI的敏感性率低于TI。金黄色葡萄球菌的苯唑西林敏感性率FI/TI分别为36.6%/30.2%,万古霉素敏感性率分别为54.1%和49.5%。当使用实际数据比较FI与TI的累积抗菌谱时,对于需要医院感染控制的关键菌种存在很大差异。尽管计算FI很困难,但为了进行恰当的预防性抗菌治疗,抗菌谱必须按FI计算,因为FI能提供恰当的抗菌药物敏感性数据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a42/7600976/eeffd445ba1f/medicina-56-00507-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a42/7600976/eeffd445ba1f/medicina-56-00507-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a42/7600976/eeffd445ba1f/medicina-56-00507-g001.jpg

相似文献

1
Importance of Susceptibility Rate of 'the First' Isolate: Evidence of Real-World Data.“首份”分离株药敏率的重要性:真实世界数据的证据
Medicina (Kaunas). 2020 Sep 28;56(10):507. doi: 10.3390/medicina56100507.
2
Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the United States: results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007.美国革兰氏阴性菌和革兰氏阳性菌的抗菌药敏率最新情况:2005年至2007年替加环素评估与监测试验(TEST)结果
Clin Ther. 2008 Nov;30(11):2040-50. doi: 10.1016/j.clinthera.2008.11.006.
3
Antimicrobial susceptibility among Gram-positive and Gram-negative organisms collected from the Latin American region between 2004 and 2015 as part of the Tigecycline Evaluation and Surveillance Trial.作为替加环素评估与监测试验的一部分,2004年至2015年间从拉丁美洲地区收集的革兰氏阳性和革兰氏阴性生物体的抗菌药敏性。
Ann Clin Microbiol Antimicrob. 2017 Jul 12;16(1):50. doi: 10.1186/s12941-017-0222-0.
4
[Surveillance of resistance in the intensive care units using a cumulative antibiogram].[使用累积抗菌谱监测重症监护病房的耐药情况]
Mikrobiyol Bul. 2018 Oct;52(4):329-339. doi: 10.5578/mb.67408.
5
[Microbiological profiles of pathogens causing nosocomial bacteremia in 2011, 2013 and 2016].[2011年、2013年和2016年医院获得性菌血症病原菌的微生物学特征]
Sheng Wu Gong Cheng Xue Bao. 2018 Aug 25;34(8):1205-1217. doi: 10.13345/j.cjb.180192.
6
Analysis of cumulative antibiogram reports in intensive care units at an Egyptian University Hospital.埃及大学附属医院重症监护病房累积药敏报告分析。
J Infect Public Health. 2023 Aug;16(8):1220-1229. doi: 10.1016/j.jiph.2023.05.032. Epub 2023 May 30.
7
Antimicrobial susceptibility of gram-negative and gram-positive bacteria collected from countries in Eastern Europe: results from the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) 2004-2010.东欧国家分离的革兰氏阴性和革兰氏阳性细菌的抗菌药物敏感性:来自替加环素评价和监测试验(T.E.S.T.)2004-2010 的结果。
Int J Antimicrob Agents. 2013 Jun;41(6):527-35. doi: 10.1016/j.ijantimicag.2013.02.022. Epub 2013 Apr 13.
8
The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016.替加环素评估和监测试验;评估替加环素和其他选定抗生素对 2004 年至 2016 年期间从法国收集的革兰氏阳性和革兰氏阴性病原体的活性。
Antimicrob Resist Infect Control. 2018 May 30;7:68. doi: 10.1186/s13756-018-0360-y. eCollection 2018.
9
Antimicrobial susceptibility among gram-positive and gram-negative blood-borne pathogens collected between 2012-2016 as part of the Tigecycline Evaluation and Surveillance Trial.2012-2016 年间收集的革兰氏阳性和革兰氏阴性血源性病原体的抗菌药敏性,作为替加环素评估和监测试验的一部分。
Antimicrob Resist Infect Control. 2018 Dec 13;7:152. doi: 10.1186/s13756-018-0441-y. eCollection 2018.
10
Bacterial susceptibility in bloodstream infections: Results from China Antimicrobial Resistance Surveillance Trial (CARST) Program, 2015-2016.血流感染中的细菌药敏性:中国抗菌药物耐药监测研究(CARST)项目,2015-2016 年结果。
J Glob Antimicrob Resist. 2019 Jun;17:276-282. doi: 10.1016/j.jgar.2018.12.016. Epub 2019 Jan 3.

引用本文的文献

1
Analysis of Cumulative Antibiogram Reports in Search for Optimal Empirical Urinary Tract Infection Treatment at the Central Teaching Hospital of the Medical University of Lodz, Poland: Results of a 3-Year Surveillance.波兰罗兹医科大学中央教学医院累积抗菌谱报告分析以寻求最佳经验性尿路感染治疗方案:三年监测结果
J Clin Med. 2023 Sep 28;12(19):6270. doi: 10.3390/jcm12196270.
2
Combining Genome Surveillance and Metadata To Characterize the Diversity of Staphylococcus aureus Circulating in an Italian Hospital over a 9-Year Period.结合基因组监测和元数据描述意大利一家医院 9 年间流行的金黄色葡萄球菌多样性。
Microbiol Spectr. 2023 Aug 17;11(4):e0101023. doi: 10.1128/spectrum.01010-23. Epub 2023 Jul 17.
3

本文引用的文献

1
Antimicrobial resistance in South Korea: A report from the Korean global antimicrobial resistance surveillance system (Kor-GLASS) for 2017.韩国的抗菌药物耐药性:来自 2017 年韩国全球抗菌药物耐药性监测系统(Kor-GLASS)的报告。
J Infect Chemother. 2019 Nov;25(11):845-859. doi: 10.1016/j.jiac.2019.06.010. Epub 2019 Jul 13.
2
Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America.实施抗生素管理计划:美国传染病学会和美国医疗保健流行病学学会指南
Clin Infect Dis. 2016 May 15;62(10):e51-77. doi: 10.1093/cid/ciw118. Epub 2016 Apr 13.
3
Better antimicrobial resistance data analysis and reporting in less time.
在更短时间内实现更好的抗菌药物耐药性数据分析与报告。
JAC Antimicrob Resist. 2023 Jan 18;5(1):dlac143. doi: 10.1093/jacamr/dlac143. eCollection 2023 Feb.
4
Recovery of antimicrobial susceptibility in methicillin-resistant (MRSA): a retrospective, epidemiological analysis in a secondary care hospital, Sapporo, Japan.耐甲氧西林金黄色葡萄球菌(MRSA)抗菌药物敏感性的恢复:日本札幌一家二级护理医院的回顾性流行病学分析
PeerJ. 2021 Jun 21;9:e11644. doi: 10.7717/peerj.11644. eCollection 2021.
Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data--The Influence of Different Parameters in a Routine Clinical Microbiology Laboratory.
累积抗菌药物敏感性试验数据的分析与呈现——常规临床微生物实验室中不同参数的影响
PLoS One. 2016 Jan 27;11(1):e0147965. doi: 10.1371/journal.pone.0147965. eCollection 2016.
4
Challenges in Preparation of Cumulative Antibiogram Reports for Community Hospitals.社区医院累积抗菌谱报告编制中的挑战。
J Clin Microbiol. 2015 Sep;53(9):2977-82. doi: 10.1128/JCM.01077-15. Epub 2015 Jul 15.
5
The true cost of antimicrobial resistance.抗菌药物耐药性的真实代价。
BMJ. 2013 Mar 11;346:f1493. doi: 10.1136/bmj.f1493.
6
Epidemiology of vancomycin-resistant Enterococcus faecalis: a case-case-control study.万古霉素耐药粪肠球菌的流行病学:病例对照研究。
Antimicrob Agents Chemother. 2013 Jan;57(1):49-55. doi: 10.1128/AAC.01271-12. Epub 2012 Oct 15.
7
Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock.不恰当的抗菌治疗会导致人类感染性休克的生存率降低五倍。
Chest. 2009 Nov;136(5):1237-1248. doi: 10.1378/chest.09-0087. Epub 2009 Aug 20.
8
Appropriate vs. inappropriate antimicrobial therapy.适当与不适当的抗菌治疗。
Clin Microbiol Infect. 2008 Apr;14 Suppl 3:15-21. doi: 10.1111/j.1469-0691.2008.01959.x.
9
Emergence of antibiotic resistance during therapy for infections caused by Enterobacteriaceae producing AmpC beta-lactamase: implications for antibiotic use.产AmpCβ-内酰胺酶肠杆菌科细菌感染治疗期间抗生素耐药性的出现:对抗生素使用的影响
Antimicrob Agents Chemother. 2008 Mar;52(3):995-1000. doi: 10.1128/AAC.01083-07. Epub 2007 Dec 17.
10
The utility of hospital antibiograms as tools for guiding empiric therapy and tracking resistance. Insights from the Society of Infectious Diseases Pharmacists.医院抗菌谱作为指导经验性治疗和追踪耐药性工具的效用。来自传染病药师协会的见解。
Pharmacotherapy. 2007 Sep;27(9):1306-12. doi: 10.1592/phco.27.9.1306.